Leicester Research Archive

Leicester Research Archive >
College of Medicine, Biological Sciences and Psychology >
Cardiovascular Sciences, Department of >
Published Articles, Dept. of Cardiovascular Sciences >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/8569

Title: Recent advances in the management of type 2 diabetes mellitus: a review
Authors: Srinivasan, B.T.
Jarvis, J.
Khunti, K.
Davies, Melanie J.
Issue Date: Oct-2008
Publisher: BMJ Publishing Group
Citation: Postgraduate Medical Journal, 2008, 84 (996), pp. 524-531.
Abstract: Type 2 diabetes mellitus (T2DM) is a progressive disorder caused by a combination of insulin resistance and β cell dysfunction. It is associated with an increased and premature risk of cardiovascular disease as well as specific microvascular complications such as retinopathy, nephropathy and neuropathy. In the last 5 years new glucose lowering drugs acting on novel pathways have been developed, licensed and launched, such as the glucagon-like peptide (GLP-1) agonists (exenatide) and dipeptidyl peptidase (DPP-IV) inhibitors such as sitagliptin and vildagliptin. This review looks at these new agents in terms of their mode of action, pharmacokinetics and use in clinical practice. This review also includes new agents in the area of weight loss that may have a positive effect for glucose management—for example, rimonabant.
ISSN: 0032-5473
Links: http://dx.doi.org/10.1136/pgmj.2008.067918
Type: Article
Description: This paper was published as Postgraduate Medical Journal, 2008, 84 (996), pp. 524-531. It is available from http://pmj.bmj.com/content/84/996/524. Doi: 10.1136/pgmj.2008.067918
Metadata only entry
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:

There are no files associated with this item.

View Statistics

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.